Nitrous
Viewing r1 — Apr 26, 2026 — CURRENT
Back to HistoryInteractions, related substances, and reports reflect the current entry and are not shown for historical revisions.
Nitrous oxide (N₂O) — laughing gas, whippits, nangs — is a synthetic dissociative of the inorganic gas class. It is the shortest-acting dissociative in common use, with effects resolving in under five minutes.[1] It blocks glutamate signaling in the brain and triggers natural opioid release, producing dissociation, pain suppression, and euphoria.[2][3][4]
Psychedex is in open beta. We are still fine-tuning the generation and review process. Please double-check sources.
Joseph Priestley first synthesized it in 1772; Horace Wells introduced it as a dental anaesthetic in 1844 — making it the longest continuously used anaesthetic in medicine.[5] Recent trials have shown a single one-hour inhalation can rapidly relieve treatment-resistant depression.[6][7] Cheap cartridges drove a surge in recreational use across Europe, and the United Kingdom classified it as a controlled substance in 2023.[8]
Subjective effects include euphoria, warmth, dissociation, auditory distortion, and time alteration. The experience is defined by extreme brevity — the entire arc from first breath to baseline collapses into minutes, producing an intense burst of perceptual dissolution rather than a sustained journey. Dizziness, disorientation, headache, and nausea are common unwanted effects.
Physical and psychological dependence is low, though compulsive daily use has been documented.[9] The acute danger is asphyxiation; the chronic danger is spinal cord damage caused by the gas permanently disabling vitamin B₁₂ — standard blood tests may miss this until nerve damage has occurred.[10][11] Over 180 years of clinical use provide a strong evidence base, though recreational dose-response data remain sparse.
History[edit]
Discovery
Joseph Priestley first synthesized nitrous oxide in 1772.[5] Humphry Davy documented its psychotropic and analgesic properties through systematic self-experimentation in the late 1790s, noting that it "seems capable of destroying physical pain" and administering it to poets Samuel Taylor Coleridge and Robert Southey.[5] Despite this, neither Davy nor his contemporaries pursued surgical applications.
Clinical adoption
Horace Wells, a Hartford dentist, recognised N₂O's anaesthetic potential in 1844 after watching a public demonstration, and underwent the first documented surgery under the gas.[5] Despite a failed public demonstration at Harvard, the gas gained steady acceptance in dentistry and later expanded into labour pain suppression — premixed 50% N₂O/oxygen systems (Entonox) remain in clinical use today.[5][12]
Modern research and recreational expansion
Following the ketamine model for rapid antidepressants, a 2015 randomised trial demonstrated that N₂O rapidly relieves treatment-resistant depression.[13] Subsequent trials showed that 25% N₂O matched 50% in efficacy with fewer adverse effects,[6] and a 2025 systematic review consolidated the evidence.[7] Concurrently, cheap culinary cartridges drove recreational use across Europe, and the United Kingdom classified N₂O as a Class C controlled substance in November 2023.[8]
The name "laughing gas" dates to Humphry Davy's demonstrations in the 1790s, when subjects frequently burst into laughter — making the gas a popular attraction at travelling shows and public "frolics" throughout the nineteenth century. The terms "whippits" and "nangs" derive from the small steel cartridges used in whipped cream dispensers.
Chemistry[edit]
Structure
Nitrous oxide is a simple inorganic gas — two nitrogen atoms bonded to one oxygen atom (N–N–O). Unlike virtually all other psychoactive substances, it contains no carbon atoms, no ring structures, and no organic functional groups.
| Molecular formula | N₂O |
| Molecular weight | 44.013 g/mol |
Pharmacology[edit]
Mechanism of action
N₂O works primarily by blocking glutamate signaling in the brain. It plugs open channels in NMDA receptors — the main pathways through which neurons excite each other. Genetic research confirms this receptor type is required for N₂O's behavioural effects,[14] and N₂O binds it at a distinct site from ketamine.[2]
N₂O also triggers the release of natural opioid compounds and norepinephrine, both of which suppress pain.[3][4][15] The opioid release contributes to the euphoria characteristic of the experience.
Pharmacokinetics
N₂O has an unusually low affinity for blood,[1] so it moves in and out of the bloodstream almost instantly — effects begin within seconds and resolve within minutes. More than 99% of the dose is exhaled unchanged, bypassing liver metabolism entirely.[16] When inhalation stops, N₂O floods back from blood into the lungs and briefly displaces oxygen — a process called diffusion hypoxia.[1]
Neuroscience[edit]
Where it acts
N₂O blocks glutamate signaling between cortical and subcortical brain regions. This disrupts the coordinated brain activity that underlies normal consciousness — producing dissociation, derealization, and time alteration. Separately, it activates a pain-suppression system running from the brainstem down into the spinal cord.[15][17]
Why it matters
Blocking glutamate signaling triggers a rebound effect surge of glutamate activity that promotes new connections between neurons — particularly in prefrontal and memory circuits.[18] A single inhalation produces measurable increases in global brain connectivity lasting more than 24 hours,[19] mirroring the window during which antidepressant effects are observed.
A 2025 study found N₂O also activates cortical neurons through an entirely separate pathway — inhibiting potassium channels in the outer cortex.[20] This may explain why lower concentrations can match higher ones in antidepressant effect.
Whether lower concentrations produce equivalent brain connectivity changes remains untested — existing neuroimaging data used a single concentration.[19] The relative contributions of the potassium channel and glutamate pathways to antidepressant effects in humans are unknown, since the potassium channel data come from rodent models.[20] Whether repeated use produces tolerance to the antidepressant response is also untested.
Subjective Effects[edit]
N₂O delivers an experience compressed to its most essential moment — a sudden burst of warmth, euphoria, and perceptual dissolution that vanishes almost as fast as it arrives. There is no build or gradual descent. The experience exists entirely in a pocket of seconds, defined more by what surrounds inhalation than by any sustained arc.
Among dissociatives, N₂O shares its mechanism with ketamine but the experiences diverge sharply. Ketamine offers a gradual hour-long journey into dissociation; N₂O delivers a flash — intense, compressed, and gone before any sustained inner architecture can form. For users familiar with longer-acting dissociatives, N₂O reads as the concentrated extract, not the full experience.
Effect Grid
At common doses (8–16 g inhaled, one to two standard cartridges), the full characteristic N₂O experience manifests: pronounced euphoria, dissociation from the immediate environment, and significant time distortion — seconds may feel stretched or compressed. Auditory distortions are common, including a characteristic oscillating or "wah-wah" quality to sounds. Mild geometric visual disturbances and a strong sense of bodily lightness or floating emerge.
Physically, dizziness is pronounced and motor control is substantially impaired — remaining seated is essential. Anxiety suppression is strong. Cognitive impairment is moderate, with slowed processing and impaired short-term memory. The peak lasts 15–30 seconds, with full resolution within 1–5 minutes.
Modeled from the effect's dose-dependence curve — not per-substance measurements.
Touch suppression · Depth perception distortion · Perspective distortion · Visual acuity suppression · Visual haze / noise · Geometry · Synesthesia · Visual processing suppression · Internal hallucinations · External hallucinations
Visual haze / noise · Geometry · Synesthesia · Visual processing suppression · Internal hallucinations · External hallucinations
Body high · Pain suppression · Vibrations / buzzing · Tactile euphoria · Breathing alteration · Laughter fits · Sedation · Body schema distortion · Muscle relaxation · Headache · Nystagmus (eye wobbles) · Physical fatigue · Nausea · Heart rate perception changes · Vomiting · Bodily dissociation
Breathing alteration · Laughter fits · Sedation · Body schema distortion · Muscle relaxation · Headache · Nystagmus (eye wobbles) · Physical fatigue · Nausea · Heart rate perception changes · Vomiting · Bodily dissociation
Memory suppression · Thought deceleration · Confusion · Focus suppression · Information processing suppression · Humor enhancement · Pattern recognition suppression · Suggestibility enhancement · Thought disorganization · Thought loops · Language suppression · Memory fragmentation · Amnesia
Focus suppression · Information processing suppression · Humor enhancement · Pattern recognition suppression · Thought disorganization · Thought loops · Language suppression · Memory fragmentation · Amnesia
Sociability enhancement · Craving · Cognitive disconnection
Timeline
First perceptible effects within seconds of inhalation — a faint light-headedness and warmth signal the gas reaching the CNS.
Rapid intensification over seconds. Euphoria, tingling, and auditory changes build quickly as blood-brain equilibration completes.
Maximum dissociation, euphoria, and perceptual distortion. Time distortion is most pronounced. Motor control is impaired; remain seated.
Effects fade rapidly as N₂O is exhaled. Cognitive clarity returns within 1–3 minutes. Mild residual dizziness and warmth may persist briefly.
Subtle residual mood elevation and mild light-headedness. Cognitive function returns to near-baseline within minutes.
⚠ Do not drive or operate machinery for at least 15 minutes after last inhalation, as residual dizziness and impaired coordination may persist.
Safety[edit]
- Acute toxicity
- Low
- Chronic toxicity
- High
- Withdrawal
- None
- Tolerance buildup
- moderate
- Tolerance reset
- 10 days
- Physical
- Negligible
- Psychological
- Low
- Compulsive redosing
- Moderate
- Dose escalation
- Low
- Cross-tol.
- —
Toxicity
Acute toxicity
N₂O is not directly toxic to cells at any achievable concentration. The acute lethal risk is asphyxiation — inhaling pure N₂O without supplemental oxygen displaces enough oxygen to cause loss of consciousness within seconds.[21] Deaths have resulted from positional suffocation (head inside a bag or attached to a delivery source) and from falls following fainting.
Diffusion hypoxia — a brief drop in oxygen as N₂O rushes back from blood into the lungs when inhalation stops — is an additional acute risk.[1]
Chronic neurotoxicity: B₁₂ inactivation
Repeated N₂O use can cause subacute combined degeneration of the spinal cord — progressive nerve damage producing tingling, numbness, unsteady gait, and weakness.[22] N₂O permanently disables vitamin B₁₂ by oxidising its central cobalt ion, destroying the enzymes needed to maintain the protective myelin sheath around nerve fibres.
N₂O causes functional inactivation of B₁₂ rather than true deficiency. Standard serum B₁₂ blood tests may return normal results even with clinically significant nerve damage.[11] Diagnosis requires measurement of homocysteine and methylmalonic acid (MMA).
A systematic review of 100 patients found the following prevalence of symptoms and findings[10]:
| Finding | Prevalence |
|---|---|
| Tingling and numbness | 80% |
| Unsteady gait | 58% |
| Weakness | 43% |
| Spinal cord degeneration | 28% |
| Nerve damage visible on MRI | 68% |
| Elevated homocysteine | 90.3% |
| Elevated MMA | 93.8% |
Median patient age was 27 years; 57% were recreational users. The characteristic MRI finding is an inverted “V-sign” on cervical spine imaging.[23] Nerve testing suggests N₂O causes damage distinct from ordinary B₁₂ deficiency — direct harm to nerve fibres beyond the metabolic pathway.[24]
B₁₂ supplementation alone does not protect against spinal cord degeneration if N₂O use continues. Cases of degeneration occurring despite supplementation have been documented.[25] Cessation of use is required.
Early treatment — stopping use plus B₁₂ replacement — usually brings gradual improvement, but recovery takes months and many patients retain residual symptoms. Irreversible nerve damage can occur with prolonged heavy use.[9]
Blood toxicity
Prolonged continuous exposure — 12–24 hours or more — produces abnormal blood cell formation.[26] Exposures under 6 hours cause no blood abnormality; changes from 12–24 hours of continuous exposure reverse within 12 hours of stopping.[27]
Cardiovascular effects
N₂O inactivates B₁₂, raising homocysteine levels — a recognised risk factor for blood clots.[16] However, a large surgical trial (n = 7,112) found no increase in cardiovascular death or major cardiovascular events at one year.[28]
Occupational exposure
Chronic occupational exposure in unscavenged medical settings is linked to reproductive harm in animals at high concentrations.[29] Workplace scavenging systems and exposure limits are recommended.[1]
Psychological Risks
At recreational doses, acute psychological effects are mild and resolve within minutes: transient anxiety, dizziness, and confusion. Prolonged heavy use has been linked to psychosis and delirium, particularly when B₁₂ deficiency is also present.[30]
The likely mechanism is elevated homocysteine disrupting glutamate signaling in the brain[31] — the same metabolic damage that harms the spinal cord can also destabilize brain function. No data exist on persistent perceptual changes following N₂O use; its dissociative rather than serotonergic mechanism makes this unlikely.
Tolerance & Dependence
Physical and psychological dependence is low; no formal withdrawal exists. Compulsive use at high daily frequency has been documented,[9] and survey data found a minority of recreational users showing patterns consistent with problematic use.[32]
Two mechanisms likely drive reinforcement: natural opioid release (direct reward) and dopamine release via glutamate blockade, similar to ketamine and PCP.[9] A diagnostic review confirmed dependence risk.[33] No data exist on cross-tolerance with other NMDA antagonists at recreational doses; seed tolerance values (half-life: 5 days; full reset: 1.5 weeks) lack published verification.citation needed
Drug Interactions
N₂O is not metabolized by liver enzymes and does not affect the metabolism of other drugs. All interactions are effect-based — they arise from overlapping actions on the nervous system.
N₂O is routinely combined with opioids in clinical anaesthesia, reducing their dose requirements.[34] At recreational doses, combining N₂O's natural opioid activation with external opioids carries theoretical additive respiratory depression risk — no dose-response or safety studies exist for this combination. Combinations with alcohol, GHB/GBL, and benzodiazepines carry additive sedation and increased oxygen deprivation risk. N₂O has no serotonergic mechanism; serotonin syndrome risk is not established.
Contraindications
Vitamin B₁₂ deficiency — including pernicious anaemia, strict vegan diets without supplementation, and absorption disorders — is an absolute contraindication. Pre-existing B₁₂ depletion dramatically accelerates the onset of spinal cord degeneration.[1][35]
Closed gas-containing body cavities — collapsed lung, bowel obstruction, middle ear disease, or recent eye surgery involving gas — are absolute contraindications. N₂O diffuses into gas-filled spaces approximately 34 times faster than nitrogen leaves, dangerously expanding cavity pressure.[12][1]
Pre-existing nerve damage or spinal cord disease is a relative contraindication, as B₁₂ inactivation may accelerate neurological decline.
First trimester of pregnancy is a relative contraindication based on animal data showing reproductive harm at prolonged exposures.[29][35]
Harm Reduction[edit]
Forms & Identification
N₂O is most commonly encountered as gas discharged from small steel cartridges (8 g “whippits” or “nangs”) into balloons, or from larger medical and catering cylinders. The gas itself is colourless and nearly odourless — there is no way to identify it by sight or smell.
The primary concern is not adulteration but delivery method. Gas inhaled directly from a pressurised source risks cold burns to the mouth, throat, and lungs, and eliminates the self-limiting oxygen mixing that a balloon provides. Cartridges marketed as food-grade and medical-grade contain the same compound.
Guidelines
- Always inhale from a balloon, never directly from a cartridge or pressurised tank — the balloon acts as a volume limiter and allows air mixing between breaths
- Maintain adequate oxygen supply: breathe normal air between inhalations and do not hold breaths for extended periods
- Use in a seated position on a soft surface to reduce fall and head injury risk
- Do not place bags, masks, or any enclosure over the head — this is the primary mechanism of N₂O-related death
- Space sessions by several minutes to allow oxygen levels to normalise between uses
- Do not use alone at high doses — impaired consciousness may prevent self-rescue from oxygen deprivation
- Anyone using N₂O regularly (weekly or more) should supplement with vitamin B₁₂ and consider periodic homocysteine and MMA blood testing — noting that supplementation does not eliminate risk if use continues[25]
- Numbness, tingling, or difficulty walking after a period of regular use are warning signs of nerve damage requiring immediate medical attention and cessation of use
Set & Setting
N₂O's extreme brevity means set and setting operate differently than for longer-acting substances. The entire experience occurs in the posture and environment at the moment of inhalation — there is no time to adjust course once begun.
Seated positions reduce fall risk during the brief period of impaired coordination. Music and ambient sound heavily shape the qualitative character of the experience. A sober companion is advisable when using higher concentrations or repeated doses, as oxygen deprivation may not be self-perceived.
Aftercare & integration. N₂O's brief duration means most users return to baseline within 5 minutes. Mild headache, dizziness, or fatigue may persist for 15–30 minutes after heavy sessions.
For those using N₂O for introspective purposes, noting impressions immediately after inhalation helps capture what the rapid return to baseline would otherwise overwrite. After sessions involving repeated dosing, fresh air and hydration support recovery. Persistent tingling, numbness, or unsteadiness after regular use requires prompt medical evaluation.
Recovery & Support
Compulsive use patterns can develop — particularly with easy access to large quantities. Warning signs include daily use, escalating consumption (tens or hundreds of cartridges per session), and continued use despite neurological symptoms.
Cessation does not require medical detoxification — there is no physical withdrawal from N₂O. The challenge is typically behavioural: breaking the pattern of compulsive re-dosing. Standard support resources — counselling, peer support, and harm reduction programmes — are appropriate. Neurological symptoms require medical evaluation first; B₁₂ replacement is standard treatment, and nerve recovery can take months.
Recovery resources, crisis lines, and support pathways → View all
Emergency Response
The critical distinction is between normal N₂O effects (brief dizziness, euphoria, disorientation resolving within minutes) and oxygen deprivation (blue or grey lips, loss of consciousness, seizure, failure to resume normal breathing after stopping inhalation). Any loss of consciousness lasting more than 30 seconds, any seizure, or any blue discolouration of the lips or fingernails requires emergency response.
Immediate steps:
- 1. Stop all N₂O administration immediately
- 2. Move the person to fresh air and ensure a clear airway
- 3. If unconscious but breathing, place in the recovery position
- 4. If not breathing, begin rescue breathing or CPR
- 5. Call emergency services if the person does not regain consciousness within 60 seconds, has a seizure, or shows signs of oxygen deprivation
What to tell the dispatcher: State that the person inhaled nitrous oxide, approximately how much (number of cartridges or duration of use), when they became unresponsive, and current symptoms. Good Samaritan laws in many jurisdictions protect people who call for help during a drug-related emergency.
For suspected nerve damage (tingling, numbness, difficulty walking after repeated use over days or weeks): this is not an acute emergency but requires urgent medical evaluation. Request homocysteine and MMA blood tests — standard B₁₂ levels may appear normal.[11]
Legal Status[edit]
N₂O is not scheduled under any United Nations drug convention,[36] though national restrictions are rapidly increasing as recreational use has grown.
| Jurisdiction | Classification | Key provisions |
|---|---|---|
| United States | Not federally scheduled | FDA-regulated as food additive; no federal scheduling under the Controlled Substances Act. Several states restrict sale to minors or sale with intent to inhale[36] |
| United Kingdom | Class C (Misuse of Drugs Act 1971), Schedule 5 | Reclassified November 2023. Possession or supply for non-medical inhalation is illegal. Medical and dental use preserved[8] |
| Australia | State-by-state regulation | Victoria: Schedule 6 poison for non-therapeutic use. South Australia: age restriction and time-of-sale restriction. NSW: reform consultation underway[36] |
| France | Restricted sale | 2023 decree limiting individual sale to cartridges ≤8.6 g in boxes of ≤10citation needed |
| European Union | Under review | EU Commission considering harmonised classification as reproductive toxicant (2024)citation needed |
| Belgium / Netherlands | National restrictions | Various restrictions on large-format tanks popular for recreational use[36] |
| Canada | Not federally scheduled | Health Canada has issued recalls of N₂O chargers marketed for inhalation without authorisation[36] |
The global trend is toward increasing restriction while preserving access for medical, dental, and food industry applications. N₂O's status as a greenhouse gas approximately 300 times more potent than CO₂ adds an environmental policy dimension absent from most controlled substance debates.[1]
Legal status changes frequently. This information reflects known classifications as of the article's last update and is not legal advice.
references
- [1]
- [2] ^abOgata J et al. (2006) Effects of anesthetics on mutant N-methyl-D-aspartate receptors expressed in Xenopus oocytes — Journal of pharmacology and experimental therapeutics PMID:16622040
- [3] ^abBranda EM, Ramza JT, Cahill FJ, Tseng LF, Quock RM (2000) Role of brain dynorphin in nitrous oxide antinociception in mice — Pharmacology, biochemistry, and behavior PMID:10672972
- [4] ^abKoyama T et al. (2009) Deletion of mu-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia — British Journal of Anaesthesia doi:10.1093/bja/aep246
- [5]
- [6] ^abNagele P et al. (2021) A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression — Science Translational Medicine doi:10.1126/scitranslmed.abe1376